ArticleTravel medicine and infectious disease

No evidence of clinical benefits of early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: Comment on "Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France".

David Lebeaux et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.